PRPO – precipio, inc. (US:NASDAQ)
Stock Stats
News
3/17
05:00 pm
prpo
Medium
Precipio Announces Q4 and year-end 2024 Shareholder Update Call
2/25
05:01 pm
prpo
High
Precipio reports Q4 results [Seeking Alpha]
2/25
10:34 am
prpo
Medium
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) [Yahoo! Finance]
2/25
09:30 am
prpo
High
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
1/16
05:00 pm
prpo
Low
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs
4/4
05:00 pm
prpo
High
Form 4 Precipio, Inc. For: Apr 02 Filed by: Sabet Ahmed Zaki
3/27
04:16 pm
prpo
Medium
Form 10-K Precipio, Inc. For: Dec 31
3/17
05:20 pm
prpo
Medium
Form 8-K Precipio, Inc. For: Mar 17
1/21
04:00 pm
prpo
Neutral
Form 8-K Precipio, Inc. For: Jan 14
1/16
05:20 pm
prpo
Low
Form 4 Precipio, Inc. For: Jan 14 Filed by: Valauri Christina Rizopoulos
Show more
Top News Gainers
9/26 Clinical Validations for IV-Cell™ and HemeScreen™ Completed 58.7%
12/17 Precipio Announces First IV-Cell Commercial Order from Northwell Health 23.2%
4/13 Form 424B3 Precipio, Inc. 17.5%
1/13 Precipio announces shareholder update call to kick off 2020 12.0%
4/29 Form DEF 14A Precipio, Inc. For: Jun 25 9.9%
11/13 Precipio's (PRPO) CEO Ilan Danieli on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.3%
8/19 Precipio reports Q2 results [Seeking Alpha] 7.7%
6/10 Form 4 Precipio, Inc. For: Jun 07 Filed by: DANIELI ILAN 7.1%
1/15 Precipio Provides Clarification To Recent S-1 Filing 5.9%
1/28 Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing 5.8%
Top News Decliners
3/20 Company Update During the COVID-19 Era -21.2%
6/17 Precipio CEO Provides Update Letter To Shareholders -20.1%
2/18 Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership -15.3%
9/26 Form 8-K Precipio, Inc. For: Sep 26 -15.1%
4/6 Precipio Launches New HemeScreen™ Reagent Rental Program -13.6%
1/28 TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service -12.9%
5/6 Precipio, Inc. (PRPO) CEO Ilan Danieli on Shareholder Update Conference (Transcript) [Seeking Alpha] -10.8%
8/21 Form 424B3 Precipio, Inc. -7.8%
5/15 Form 8-K Precipio, Inc. For: May 15 -7.0%
8/14 Form 8-K Precipio, Inc. For: Aug 13 -6.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3